Journal
ANNALS OF ONCOLOGY
Volume 28, Issue -, Pages 52-61Publisher
OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdx096
Keywords
-
Categories
Funding
- Amgen
- Celgene
- Janssen
- Tanken
- Karyopharm
- Takeda
- Novartis
- Chugai
- Bristol-Myers Squibb
- Roche